Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_assertion type Assertion NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_head.
- NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_assertion description "[After successful remission induction with single-agent chemotherapy (VM-26) and subsequent sustained remission for 12 months with alternating VM-26 and VP-16-213, lineage switch to ALL (FAB L1) occurred.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_provenance.
- NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_assertion evidence source_evidence_literature NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_provenance.
- NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_assertion SIO_000772 2751072 NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_provenance.
- NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_assertion wasDerivedFrom befree-20140225 NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_provenance.
- NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_assertion wasGeneratedBy ECO_0000203 NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_provenance.